Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
Mais filtros

Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Respiration ; 102(2): 154-163, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36603552

RESUMO

BACKGROUND: Several minimally invasive treatments have been offered to patients with severe emphysema over the last two decades. Currently, endobronchial valves (EBVs) are the only approved therapeutic option, but this method has drawbacks: only a few can undergo this therapy and the incidence of pneumothorax remains high. A minimally invasive technique, appropriate for a broader patient population and posing fewer risks, would represent a desirable alternative to improve lung function in these patients. OBJECTIVE: The objective of this study was to demonstrate whether a new prototype implantable artificial bronchus (IAB) releases trapped air from the lungs of recently deceased patients with emphysema. METHOD: Seven recently deceased patients with emphysema were mechanically ventilated and the respiratory rate increased from 12 bpm (resting) to 30 bpm (exercise), inducing air trapping and dynamic hyperinflation. This protocol was performed twice, before and after IAB placement. Ventilation parameters and the fraction of inspired oxygen were similar in all patients. Respiratory system plateau pressure (Pplat,rs) and intrinsic positive end-expiratory pressure (iPEEP) were measured. RESULTS: IAB implantation significantly reduced Pplat,rs (p = 0.017) in 6 of 7 deceased patients with emphysema and iPEEP (p = 0.03) in 5 of 7 patients. CONCLUSIONS: Placement of one or two IABs in segmental bronchi (up to 15th generation) proved to be feasible and improved lung function. These findings should provide a basis for subsequent clinical studies to assess the safety and efficacy of IAB in patients with emphysema, as well as identify short- and long-term effects of this innovative procedure.


Assuntos
Enfisema , Enfisema Pulmonar , Humanos , Enfisema/cirurgia , Pulmão , Brônquios , Próteses e Implantes
2.
Mycopathologia ; 174(2): 163-9, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22382738

RESUMO

Emerging reports have associated chronic pulmonary obstructive disease (COPD) with invasive aspergillosis (IA), particularly in patients treated with mechanical ventilation and/or corticosteroids. This is a multicentre study in which COPD patients demonstrating a new lung infiltrate while being mechanically ventilated were prospectively evaluated for the presence of IA. From the 47 patients studied, Aspergillus fumigatus was recovered in culture in two patients (4.2%). While serum galactomannan (GM) was negative for 94% of patients, GM levels in respiratory samples were >0.5, >1.0 and >1.5 for 74.5, 40.5, and 21.3% of patients, respectively. PCR was positive for 10 patients in the study but did not differentiate Aspergillus colonization from infection. The combination of PCR and GM in respiratory samples may be an interesting alternative to diagnose IA in COPD patients.


Assuntos
Aspergillus fumigatus/crescimento & desenvolvimento , Aspergillus fumigatus/isolamento & purificação , Aspergilose Pulmonar Invasiva/diagnóstico , Mananas/análise , Técnicas Microbiológicas/métodos , Micologia/métodos , Reação em Cadeia da Polimerase em Tempo Real/métodos , Idoso , Idoso de 80 Anos ou mais , Estudos de Coortes , Feminino , Galactose/análogos & derivados , Humanos , Aspergilose Pulmonar Invasiva/complicações , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Doença Pulmonar Obstrutiva Crônica/complicações
4.
Crit Care ; 10(5): R133, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16978415

RESUMO

INTRODUCTION: Outcome after cardiac arrest is mostly determined by the degree of hypoxic brain damage. Patients recovering from cardiopulmonary resuscitation are at great risk of subsequent death or severe neurological damage, including persistent vegetative state. The early definition of prognosis for these patients has ethical and economic implications. The main purpose of this study was to investigate the prognostic value of serum neuron-specific enolase (NSE) in predicting outcomes in patients early after in-hospital cardiac arrest. METHODS: Forty-five patients resuscitated from in-hospital cardiac arrest were prospectively studied from June 2003 to January 2005. Blood samples were collected, at any time between 12 and 36 hours after the arrest, for NSE measurement. Outcome was evaluated 6 months later with the Glasgow outcome scale (GOS). Patients were divided into two groups: group 1 (unfavorable outcome) included GOS 1 and 2 patients; group 2 (favorable outcome) included GOS 3, 4 and 5 patients. The Mann-Whitney U test, Student's t test and Fisher's exact test were used to compare the groups. RESULTS: The Glasgow coma scale scores were 6.1 +/- 3 in group 1 and 12.1 +/- 3 in group 2 (means +/- SD; p < 0.001). The mean time to NSE sampling was 20.2 +/- 8.3 hours in group 1 and 28.4 +/- 8.7 hours in group 2 (p = 0.013). Two patients were excluded from the analysis because of sample hemolysis. At 6 months, favorable outcome was observed in nine patients (19.6%). Thirty patients (69.8%) died and four (9.3%) remained in a persistent vegetative state. The 34 patients (81.4%) in group 1 had significantly higher NSE levels (median 44.24 ng/ml, range 8.1 to 370) than those in group 2 (25.26 ng/ml, range 9.28 to 55.41; p = 0.034). CONCLUSION: Early determination of serum NSE levels is a valuable ancillary method for assessing outcome after in-hospital cardiac arrest.


Assuntos
Parada Cardíaca/enzimologia , Parada Cardíaca/epidemiologia , Hospitalização , Fosfopiruvato Hidratase/sangue , Idoso , Biomarcadores/sangue , Reanimação Cardiopulmonar , Estudos de Coortes , Feminino , Parada Cardíaca/terapia , Humanos , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Prognóstico , Estudos Prospectivos , Fatores de Tempo , Resultado do Tratamento
6.
Clinics (Sao Paulo) ; 70(5): 326-32, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-26039948

RESUMO

OBJECTIVE: Studies suggest an association between vitamin D deficiency and morbidity/mortality in critically ill patients. Several issues remain unexplained, including which vitamin D levels are related to morbidity and mortality and the relevance of vitamin D kinetics to clinical outcomes. We conducted this study to address the association of baseline vitamin D levels and vitamin D kinetics with morbidity and mortality in critically ill patients. METHOD: In 135 intensive care unit (ICU) patients, vitamin D was prospectively measured on admission and weekly until discharge from the ICU. The following outcomes of interest were analyzed: 28-day mortality, mechanical ventilation, length of stay, infection rate, and culture positivity. RESULTS: Mortality rates were higher among patients with vitamin D levels <12 ng/mL (versus vitamin D levels >12 ng/mL) (32.2% vs. 13.2%), with an adjusted relative risk of 2.2 (95% CI 1.07-4.54; p< 0.05). There were no differences in the length of stay, ventilation requirements, infection rate, or culture positivity. CONCLUSIONS: This study suggests that low vitamin D levels on ICU admission are an independent risk factor for mortality in critically ill patients. Low vitamin D levels at ICU admission may have a causal relationship with mortality and may serve as an indicator for vitamin D replacement among critically ill patients.


Assuntos
Deficiência de Vitamina D/sangue , Deficiência de Vitamina D/mortalidade , Vitamina D/sangue , APACHE , Adulto , Idoso , Brasil/epidemiologia , Estado Terminal , Diálise , Feminino , Mortalidade Hospitalar , Humanos , Unidades de Terapia Intensiva/estatística & dados numéricos , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Escores de Disfunção Orgânica , Hormônio Paratireóideo/sangue , Admissão do Paciente , Alta do Paciente , Estudos Prospectivos , Respiração Artificial , Risco , Sensibilidade e Especificidade
7.
Am J Infect Control ; 41(11): 1012-6, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23972518

RESUMO

BACKGROUND: Hand hygiene is the most important measure to reduce health care-related infections and colonization with multiresistant micro-organisms. We sought to determine the rate and seasonality of handwashing compliance in a university-affiliated hospital. METHODS: In January 2006 (baseline period), handwashing observation was first made in an intensive care unit. From March to May 2006, there was an intervention period; and, from June 2006 to August 2009, we followed hand hygiene compliance. Seasonality curves for handwashing compliance were made during follow-up period. RESULTS: During baseline period, a total of 166 observations was made. During follow-up, 17,664 opportunities for hand hygiene were observed. Compliance improved from 30.0% to a mean of 56.7% after the intervention (P < .001). The highest mean rate of compliance was 77.9% for nurses, compared with 52.6% for technicians (P < .001) and 44.6% for physicians (P < .001). Compliance was lower during summer days (first trimester of the year) and increased after March and April and slowly decreased through the end of the year. CONCLUSION: One of the reasons for the lower handwashing compliance in the first 3 months of the year is that, in Brazil, this is the summer vacation time; and, because of that, the staff's workload and the number of less well-trained personnel are higher. We emphasize the importance of continuously monitoring hand hygiene to determine the seasonal aspects of compliance.


Assuntos
Fidelidade a Diretrizes/estatística & dados numéricos , Higiene das Mãos/métodos , Brasil , Hospitais Universitários , Humanos , Unidades de Terapia Intensiva , Estações do Ano
8.
Infect Control Hosp Epidemiol ; 32(6): 584-90, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21558771

RESUMO

OBJECTIVE: To evaluate the impact of ertapenem use in Pseudomonas aeruginosa carbapenem resistance, taking into account the volume of antimicrobial consumption, the consumption by the entire hospital of alcohol-based antiseptic hand rub, and the density rate of invasive practices. DESIGN: Before-and-after trial. SETTING: A tertiary care university hospital in southern Brazil. METHODS: Ertapenem was first added to the hospital formulary in June 2006, and it was excluded in February 2009. We evaluated Pseudomonas aeruginosa resistance rates through 3 study periods: period 1, before ertapenem use (17 months); period 2, during ertapenem use (33 months); and period 3, after exclusion of ertapenem (15 months). RESULTS: After introduction of ertapenem, there was a significant decrease in median consumption of imipenem or meropenem, from 2.6 to 2.2 defined daily doses (DDDs) per 100 patient-days (level change from 0.04 to -1.08; P < .01), and an increase in the use of these medications after ertapenem exclusion, from 2.2 to 3.3 DDDs per 100 patient-days (level change from -0.14 to 0.91; P < .01), by segmented regression analysis. There was no difference in the incidence density of carbapenem-resistant P. aeruginosa infection related to ertapenem use throughout the study periods. However, by multiple regression analysis, the reduction in the rate of carbapenem-resistant P. aeruginosa infection correlated significantly with the increase in the volume of alcohol used as hand sanitizer, which was from 660.7 mL per 100 patient-days in period 1 to 2,955.1 mL per 100 patient-days in period 3 (P = .04). Ertapenem use did not impact the rate of carbapenem-resistant P. aeruginosa infection. CONCLUSIONS: Use of alcohol-based hand gel, rather than ertapenem, was associated with a reduction in the rates of carbapenem-resistant P. aeruginosa infection. Measures to reduce resistance must include factors other than just antimicrobial stewardship programs alone.


Assuntos
Antibacterianos/uso terapêutico , Desinfecção das Mãos/métodos , Infecções por Pseudomonas/prevenção & controle , Pseudomonas aeruginosa/efeitos dos fármacos , Resistência beta-Lactâmica/efeitos dos fármacos , Carbapenêmicos/uso terapêutico , Infecção Hospitalar/prevenção & controle , Ertapenem , Hospitais Universitários , Humanos , Incidência , Infecções por Pseudomonas/tratamento farmacológico , Infecções por Pseudomonas/epidemiologia , Análise de Regressão , beta-Lactamas/uso terapêutico
9.
Rev Bras Ter Intensiva ; 23(3): 269-82, 2011 Sep.
Artigo em Inglês, Português | MEDLINE | ID: mdl-23949398

RESUMO

The role of intensive care specialists in the maintenance of deceased potential donors is not restricted to hemodynamics. Appropriate endocrine-metabolic management is fundamental to maintaining energy support and hydroelectrolytic control, which cooperate for hemodynamic stability. Hematological changes are also important, especially considering the issues caused by inappropriate transfusions. In addition, this article discusses the role of appropriate protective ventilation to prevent inflammatory responses and to provide more transplantable lungs. Finally, judicious assessment of infections and antibiotic therapy is discussed.

10.
Clinics ; 70(5): 326-332, 05/2015. tab, graf
Artigo em Inglês | LILACS | ID: lil-748274

RESUMO

OBJECTIVE: Studies suggest an association between vitamin D deficiency and morbidity/mortality in critically ill patients. Several issues remain unexplained, including which vitamin D levels are related to morbidity and mortality and the relevance of vitamin D kinetics to clinical outcomes. We conducted this study to address the association of baseline vitamin D levels and vitamin D kinetics with morbidity and mortality in critically ill patients. METHOD: In 135 intensive care unit (ICU) patients, vitamin D was prospectively measured on admission and weekly until discharge from the ICU. The following outcomes of interest were analyzed: 28-day mortality, mechanical ventilation, length of stay, infection rate, and culture positivity. RESULTS: Mortality rates were higher among patients with vitamin D levels <12 ng/mL (versus vitamin D levels >12 ng/mL) (32.2% vs. 13.2%), with an adjusted relative risk of 2.2 (95% CI 1.07-4.54; p< 0.05). There were no differences in the length of stay, ventilation requirements, infection rate, or culture positivity. CONCLUSIONS: This study suggests that low vitamin D levels on ICU admission are an independent risk factor for mortality in critically ill patients. Low vitamin D levels at ICU admission may have a causal relationship with mortality and may serve as an indicator for vitamin D replacement among critically ill patients. .


Assuntos
Adulto , Humanos , Pessoa de Meia-Idade , Poluentes Ocupacionais do Ar/efeitos adversos , Poeira , Bombeiros , Pneumopatias Obstrutivas/etiologia , Síndrome Metabólica/sangue , Exposição Ocupacional/efeitos adversos , Índice de Massa Corporal , Biomarcadores/sangue , Estudos de Casos e Controles , Volume Expiratório Forçado , Modelos Logísticos , Estudos Longitudinais , Pneumopatias Obstrutivas/sangue , Pneumopatias Obstrutivas/diagnóstico , Síndrome Metabólica/complicações , Cidade de Nova Iorque , Razão de Chances , Sensibilidade e Especificidade , Espirometria
14.
Clin. biomed. res ; 31(1): 80-89, 2011. ilus
Artigo em Português | LILACS | ID: biblio-982643

RESUMO

O aumento da incidência de germes multirresistentes (GMR) e a falta de opções terapêuticas a curto ou médio prazo representam um grande desafio aos hospitais no que se refere à prevenção da disseminação destas bactérias. Para a prevenção da transmissão de agentes infecciosos no ambiente hospitalar é preconizada a adoção de medidas de bloqueio epidemiológico. Essas políticas de bloqueio devem estar claramente estabelecidas, divulgadas aos profissionais de saúde e adotadas por estes a fim de minimizar a incidência de GMR. Revisamos aqui a política de prevenção da disseminação de germes multirresistentes no Hospital de Clínicas de Porto Alegre.


The increasing incidence of multidrug-resistant organisms (MDROs) and the lack of therapeutic options in the short and medium term pose a major challenge to hospitals with regard to preventing the spread of these bacteria. Infection control measures are recommended to prevent transmission of infectious agents in hospital settings. These infection control policies should be clearly established and disseminated among health professionals in order to minimize the incidence of MDROs. We reviewed a hospital policy for prevention of transmission of MDROs at Hospital de Clínicas de Porto Alegre, southern Brazil.


Assuntos
Humanos , Infecções Bacterianas/prevenção & controle , Infecção Hospitalar/prevenção & controle , Farmacorresistência Bacteriana Múltipla , Controle de Infecções/métodos , Acinetobacter , Clostridioides difficile , Enterococcus , Infecções por Bactérias Gram-Negativas/prevenção & controle , Infecções por Bactérias Gram-Positivas/prevenção & controle , Staphylococcus aureus Resistente à Meticilina , Vigilância de Evento Sentinela
15.
Rev. bras. ter. intensiva ; 23(3): 269-282, jul.-set. 2011.
Artigo em Português | LILACS | ID: lil-602761

RESUMO

A atuação do intensivista durante a manutenção do potencial doador falecido na busca da redução de perdas de doadores e do aumento da efetivação de transplantes não se restringe aos aspectos hemodinâmicos. O adequado controle endócrino-metabólico é essencial para a manutenção do aporte energético aos tecidos e do controle hidro-eletrolítico, favorecendo inclusive a estabilidade hemodinâmica. A abordagem das alterações hematológicas é igualmente importante considerando as implicações da prática transfusional inapropriada. Ressalta-se ainda o papel da ventilação protetora na modulação inflamatória e conseqüente aumento do aproveitamento de pulmões para transplante. Por fim, assinala-se a relevância da avaliação criteriosa das evidências de atividade infecciosa e da antibioticoterapia na busca do maior utilização de órgãos de potenciais doadores falecidos.


The role of intensive care specialists in the maintenance of deceased potential donors is not restricted to hemodynamics. Appropriate endocrine-metabolic management is fundamental to maintaining energy support and hydroelectrolytic control, which cooperate for hemodynamic stability. Hematological changes are also important, especially considering the issues caused by inappropriate transfusions. In addition, this article discusses the role of appropriate protective ventilation to prevent inflammatory responses and to provide more transplantable lungs. Finally, judicious assessment of infections and antibiotic therapy is discussed.

17.
Artigo em Português | LILACS | ID: lil-552754

RESUMO

Programas de controle de antimicrobianos (PCAs) têm o objetivo de promover o uso racional de antibióticos. O uso racional de antimicrobianos melhora a eficácia do tratamento, reduz os custos relacionados aos medicamentos, minimiza eventos adversos, e reduz o potencial surgimento de resistência bacteriana. A estrutura destes PCAs foi publicada pela Sociedade Americana de Doenças Infecciosas. Uma combinação de educação, formulários de restrição de prescrição, auditoria prospectiva em antimicrobianos, feedback ao corpo clínico, são formas de estabelecer um programa de sucesso. A adesão por parte dos médicos da instituição é fundamental para o bom andamento do programa. Os PCAs devem atingir a todos os médicos na instituição independentemente da função ou experiência do profissional. Para tanto, uma diretriz de uso de antimicrobianos deve ser criada para servir de embasamento para as condutas estabelecidas e os médicos devem ter acesso a estas diretrizes. Descreveremos, a seguir, a política de antimicrobianos do Hospital de Clínicas de Porto Alegre para o ano de 2010.


Antimicrobial stewardship programs (ASPs) promote the appropriate use of antimicrobials. The appropriate use of antimicrobials has the potential to improve efficacy, reduce treatment-related costs, minimize drug-related adverse events, and limit the potential for emergence of antimicrobial resistance. The structure for antimicrobial stewardship programs has been published by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. A combination of education, formulary restriction and pre-authorization, prospective audit with intervention and feedback are forms of establishing a successful program. Gaining physicians acceptance is crucial and ASPs must apply to all physicians irrespective of experience or function in the hospital. An evidence based antimicrobial guideline must be constructed with hospital leaders and accessed by all physicians to help to disseminated antimicrobial policies. We describe Hospital de Clínicas de Porto Alegre antibiotic policies for the year of 2010.


Assuntos
Humanos , Antibacterianos/química , Antibacterianos/uso terapêutico , Planos e Programas de Saúde/normas , Planos e Programas de Saúde/organização & administração , Controle de Infecções/métodos , Controle de Infecções/normas , Programa de Controle de Infecção Hospitalar
20.
Mem. Inst. Oswaldo Cruz ; 94(3): 377-81, May-Jun. 1999. tab
Artigo em Inglês | LILACS | ID: lil-239047

RESUMO

The objective of this study is to determine the different characteristics of human immunodeficiency virus (HIV) positive and negative patients treated for tuberculosis (TBC) in a tertiary hospital in Southern Brazil. We conducted a retrospective cohort study over a 5-year period, from January 1992 through December 1996. We reviewed medical charts of patients from our institution who received TBC treatment. We reviewed 167 medical charts of patients with confirmed TBC. HIV positivity and negative patients in sex and age. HIV-infected patients showed significantly more signs of bacteremia than HIV-negative patients. Extra-pulmonary TBC was present respectively in 13 (17.6 por cento) and 21 (22.6 por cento) HIV positive and negative patients. There was a significant difference between chest radiograph presentation in HIV positive and negative patients. There were significantly lower hematocrit, hemoglobin, leukocyte and lymphocyte levels in HIV-positive compared to HIV-negative patients. Outcome was significantly different in the two groups with a death rate of 36.5 (por cento) and 10.8 (por cento) in HIV-positive and in HIV-negative patients. The difference between HIV positive and negative patients may have importance in the diagnosis, managemento and prognosis of patients with TBC.


Assuntos
Humanos , Soropositividade para HIV/complicações , HIV/imunologia , Mycobacterium tuberculosis/imunologia , Tuberculose/complicações , Tuberculose/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA